10
Dec
Panel: The future of Mass Tort Bankruptcies in the US
The recent Purdue Pharma Supreme Court ruling, which barred the issuance of non-consensual third-party releases in Chapter 11 plans, will have huge consequences for future mass tort cases. Separately, a bi-partisan bill has been introduced seeking to curtail Texas Two-Step bankruptcies, and whilst its passage is not guaranteed, its introduction signals growing scrutiny of corporate bankruptcy tactics and might signal a rise in legislative and judicial focus on these issues. Our panel of experts will unpack the latest updates and discuss the implications of the decision and what it means for Chapter 11 cases going forward.
- Case study: what are the potential ramifications of the Purdue decision for the restructuring industry and the resolution of mass torts?
- Updates on the J&J/LTL Management bankruptcy case- what’s next?
- Is the Texas Two-Step here to stay, or is it losing steam?
- Industry views- what is next for Chapter 11 mass tort cases? How will the industry continue to evolve?
-
SpeakersSaul Burian Managing Director HOULIHAN LOKEY
Hon. Michael B. Kaplan Chief Bankruptcy Judge DISTRICT OF NEW JERSEYRachael Ringer Partner, Co-Head, Distressed Investing KRAMER LEVIN
Andy Serbe Senior Legal Reporter DEBTWIRE
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports